BioSpace News Archive

ImmunityBio, Inc., a publicly traded immunotherapy company, announced today that it has been granted a patent by the U.S. Patent and Trademark Office for its proprietary NANT Cancer Vaccine (U.S. Patent 11,071,774).

Ampio Pharmaceuticals announced details on the Company’s poster presentation, “Inflammation and COVID Induced ARDS: Inhaled Ampion™ as a Therapeutic Option,” being given at the 63rd annual Thomas L. Petty Aspen Lung Conference, September 20 to 23, 2021, at the Gant Conference Center in Aspen, Colorado.

Advancing the development of its proprietary Bio-RFIDTM platform technology while continuing to deliver against its IP strategy, Know Labs, Inc. (OTCQB: KNWN) today announced it has been granted three new patents that support its medical diagnostic focus while also signaling potential for additional non-medical applications.